Genenta Science S.p.A (GNTA) Payables (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Payables of $1.8 million for Q4 2025, up 54.67% sequentially from $1.1 million in Q2 2025, and up 417.28% YoY from $339631.7 in Q4 2024.
Genenta Science S.p.A (GNTA) Payables (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Payables for 6 years, with the latest figure at $1.8 million in Q4 2025.
- Quarterly Payables rose 417.28% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (up 417.28% YoY) and the FY2025 annual result came in at $1.8 million, up 417.28% from the prior year.
- Payables climbed to $1.8 million in Q4 2025 per GNTA's latest filing, from $1.1 million in the prior quarter.
- Over five years, Payables peaked at $1.8 million in Q4 2025 and troughed at $217201.2 in Q4 2021.
- A 5-year average of $689805.7 and a median of $437050.5 in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2025: Payables slumped 70.15% in 2023, then soared 417.28% in 2025.
- Over 5 years, Payables stood at $217201.2 in 2021, then soared by 389.48% to $1.1 million in 2022, then plunged by 70.15% to $317375.4 in 2023, then increased by 7.01% to $339631.7 in 2024, then soared by 417.28% to $1.8 million in 2025.
- According to Business Quant data, Payables over the past three periods registered $1.8 million, $1.1 million, and $339631.7 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Genenta Science S.p.A | 23.36 Mn | -35.73 Mn | - | 1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Dec 31, 2024 | 339,631.68 |
| Jun 30, 2024 | 437,050.52 |
| Dec 31, 2023 | 317,375.37 |
| Jun 30, 2023 | 380,332.98 |
| Dec 31, 2022 | 1.06 Mn |
| Jun 30, 2022 | 560,807.65 |
| Dec 31, 2021 | 217,201.19 |
| Dec 31, 2020 | 649,783.66 |